Literature DB >> 20967869

Survival of patients with palliative head and neck cancer.

Quirine C P Ledeboer1, Marc P van der Schroeff, Jean F A Pruyn, Maarten F de Boer, Robert J Baatenburg de Jong, Lilly-Ann van der Velden.   

Abstract

BACKGROUND: The purpose of this study was to describe patient characteristics and prognostic factors for survival in the palliative stage of patients with head and neck cancer.
METHODS: Since November 2003, all patients with palliative head and neck cancer treated in our hospital have been recorded in a central database. In total, 262 deceased patients were included in this retrospective study.
RESULTS: The reasons for palliation were inoperability, distant metastases, refusal of curative treatment, or poor condition. The mean palliative phase lasted 5.3 months for patients with squamous cell carcinomas. Involvement of a specialized nurse was significantly related with the number of admissions and place of dying. Multivariate analysis showed comorbidity and treatment to be independent predictors of survival in the palliative phase.
CONCLUSION: Comorbidity and palliative interventions are possible prognostic factors for survival. The involvement of a specialized nurse might be associated with an improved quality of life.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20967869     DOI: 10.1002/hed.21572

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  End-of-life care pathway of head and neck cancer patients: single-institution experience.

Authors:  T Heinonen; V Loimu; K Saarilahti; T Saarto; A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-15       Impact factor: 2.503

2.  Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.

Authors:  Naomi van der Linden; Jan Buter; Chris P Pescott; Roy I Lalisang; Jan Paul de Boer; Alexander de Graeff; Carla M L van Herpen; Robert J Baatenburg de Jong; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-21       Impact factor: 2.503

3.  Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.

Authors:  Charbél Talani; Antti Mäkitie; Martin Beran; Erik Holmberg; Göran Laurell; Lovisa Farnebo
Journal:  PLoS One       Date:  2019-10-02       Impact factor: 3.240

4.  Physicians' clinical prediction of survival in head and neck cancer patients in the palliative phase.

Authors:  Arta Hoesseini; Marinella P J Offerman; Bojou J van de Wall-Neecke; Aniel Sewnaik; Marjan H Wieringa; Robert J Baatenburg de Jong
Journal:  BMC Palliat Care       Date:  2020-11-24       Impact factor: 3.234

5.  [Randomized controlled trial for palliative radiotherapy of head and neck cancer-challenges remain].

Authors:  Alexander Fabian; David Krug; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2020-11       Impact factor: 3.621

6.  Patient-Reported Outcomes Assessing the Impact of Palliative Radiotherapy on Quality of Life and Symptom Burden in Head and Neck Cancer Patients: A Systematic Review.

Authors:  Alexander Fabian; Justus Domschikowski; Markus Hoffmann; Oliver Weiner; Claudia Schmalz; Jürgen Dunst; David Krug
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.